Ziraoui, N.-E. et al. 2026. BCLC™ NAD⁺ Supplement System Targeting SIRT1: A Time-Sequential Biphasic NMN-Resveratrol-Quercetin Formulation with Supporting Clinical and Pharmacological Evidence. International Journal of Public Health and Medical Research. 6, 4 (Apr. 2026), 36–44. DOI:https://doi.org/10.62051/ijphmr.v6n4.06.